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Studies were performed to investigate the effects ofFireMaster FF-1, a chemical fire retardant consist-
ing of a mixture of polybrominated biphenyls (PBB), on immune functions in mice and rats. Animals
received 22 daily treatments of 0.03, 0.3, 3.0, or 30 mg PBB/kg body weight in a period covering 30
days. PBB exposure severely depressed cell mediated immunity in both mice and rats at the higher dosage
levels as indicated by depressed responsiveness of splenic lymphocytes to mitogenic stimulation by poly-
clonal T-cell activators. Additionally, humoral immunity was depressed in mice at the 30.0 ppm dosage
level. Assays for humoral immune functions included antibody production, serumimmunoglobulin levels,
and mitogenic stimulation ofsplenic lymphocytes to a polyclonal B-cell activator. These studies indicate
that PBB exposure can lead to suppression of both humoral and particularly cell-mediated immune
responses.
Immunosuppression by environmental chemicals
in a developing concern in chronic toxicity assess-
ment. As recently reviewed by Vos (1), a number of
these chemicals have been found to severely sup-
press immune functions. For example, the or-
ganometallics, including triphenyltin and methyl-
mercury as well as inorganic metals such as lead,
mercury, and cadmium, suppress humoral immune
functions. In contrast, the polychlorinated hy-
drocarbon, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) has been reported to suppress cell-
mediated immune functions while polychlorinated
biphenyl (PCB) and di-n-butyltin dichloride sup-
press both cellular and humoral immune functions.
In 1973 FireMaster PB-6, a chemical fire retar-
dant consisting of a mixture of polybrominated
biphenyls (PBB), was accidentally mixed with
livestock feed in the State ofMichigan. As a result,
over 15 million livestock including 11,000 beef and
dairy cattle had to be destroyed in 1974 alone (2).
During the first 9 months following the accident,
meat and dairy products containing PBB were
widely consumed in Michigan. Subsequently, PBB
was found in the serum and/or adipose tissues of
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dairy farmers in the state as well as many urban
residents ofMichigan (3, 4). While many cattle died
due to PBB-induced ailments and some pregnant
animals may have aborted, there is no clear-cut evi-
dence for similar effects in humans to date. How-
ever, Bekesi et al. (in press) recently indicated that
Michigan dairy farm residents who ate farm prod-
ucts containing PBB following accidental con-
tamination ofanimal feed in 1973, presumably a low
dose chronic exposure, have significant alterations
in their immune status. The studies reported here
were undertaken to investigate the effects of an
identical commercial preparation of PBB (Fire-
Master FF-1) on the immune response of mice and
rats.
Materials and Methods
Animals
Male Fisher rats (CDF) and female mice (B6C3F,)
were purchased from NCI (Fort Detrick, Md.).
Animals were housed in hanging wire mesh cages
and allowed free access to food and water. Separate
animals were used for in vitro lymphocyte culture
and antibody tests.
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FireMaster (FF-1) (lot #FF1312FT, Batch 03)
was obtained from Midwest Research Institute.
Mass spectral analysis indicated that the mixture
was > 99%o PBB with 56% ofthe mixture containing
2,4,5,2',4',5'-hexabromobiphenyl (HBB) and 27%
consisting of 2,3,4,5,2',4',5'-heptabromobiphenyl
(R. Hass, unpublished observations). The Fire-
Master was dissolved in corn oil and so diluted that
mice received a total volume of 0.1 ml and rats re-
ceived a total of 0.2 ml per dosage.
Dosage Regimen
Mice and rats were randomly grouped and treated
with 0.03, 0.3, 3.0, or 30.0 mg PBB/kg body weight
per day. Controls received corn oil alone. Animals
were dosed by gavage 5 days per week until 22
doses were administered (a period covering 30
days). Functional immune studies were performed
26-34 days following the final dose in order to view
clinical changes.
Cell Preparation
Animals used for in vitro lymphocyte cultures or
antibody plaque assays were killed with CO2 and
their spleens removed aseptically. Cell suspensions
were prepared as previously described (Luster and
Faith, in press). Cell counts were determined with a
Coulter Counter (Model ZB, Coulter Electronics,
Inc., Hialeah, Fla.).
Cell Cultures
The lymphoid cells obtained from individual
spleens were cultured as previously described
(Luster and Faith, in press). Cell stimulation was
measured by the rate of cellular DNA synthesis as
determined by incorporation of 3H-thymidine into
acid-insoluble material. In mice, the mitogens and
concentrations in culture media employed were
phytohemagglutinin-P (PHA) at 8 ,ug/ml, Con-
conavalin A (Con A) at 2 gg/ml and E. coli lipo-
polysaccharide 0127 (LPS) (Difco Lab.) at25 ,ug/ml.
In rats, the concentrations were 50 ug/ml PHA, 4
gg/ml Con A, and 100 gg/ml of pokeweed mitogen
(PWM) (Gibco Lab.).
Humoral Immune Function Tests
Serum IgG, IgM, and IgA levels were quantified
on individual serum by the radial immunodiffusion
technique (5) with the use of commercial heavy
chain-specific antisera and standards (Meloy Lab.,
Springfield, Va.). IgM (19s) plaque forming cells
(PFC) to sheep red blood cells (SRBC) were deter-
mined by the antibody plaque assay in mice (6). A
microtiter (Cooke Engineering, Alexandria, Va.)
technique was used to assay rat hemagglutinins to
SRBC. Individual mice and rats were tested for
their ability to produce an antibody response 4 days
following intraperitoneal immunization with 0.1 ml
of a 10o suspension of washed SRBC.
Statistical Analysis
Forin vitro stimulation, the Mann-Whitney U test
was employed to assess the significance of treat-
ment effects (7). The significance of dose response
trends was determined by Jonckheere's test. For
immunoglobulin quantitation and the antibody
plaque assay statistical analysis was performed on
the geometric means oftransformed data employing
analysis of variance procedures (8).
Results
All mice and rats treated with PBB survived the
experimental period. Table 1 records body and
selected organ weights of mice orally dosed with
PBB at levels of0, 0.03, 0.3, 3.0, and 30 mg/kg body
weight for 22 days over a 30-day period. In mice,
necropsied 30 days after the final exposure, an ab-
solute and relative decrease in spleen as well as a
slight reduction in thymus weight occurred at the 30
ppm dose level. Microscopic examination of the
lymphoid organs at 30 days following the last expo-
sure failed to reveal visible effects, although a slight
decrease inthedensity ofthymic cortexwasnoted at
the30mg/kgdoselevel.
Body weights and selected organ weights of rats
necropsied 30 days after the final exposure are
given in Table 2. A marked reduction in body
weight, spleen weight, as well as absolute and rela-
tive thymic weights were noted at the 30 mg/kg dose
level. Reduced absolute spleen weights as well as
relative spleen and thymus weights also occurred in
the 3.0 mg/kg dosage group. Microscopically,
minimal effects were observed in the spleen or
thymus exceptfor a slight decrease in the density of
the thymic cortex in the 30 mg/kg group.
Figure 1 depicts the reactivity ofsplenic lympho-
cytes from PBB exposed mice to mitogen stimu-
lation by the mitogens Con A, PHA and LPS as
well as the antibody plaque-forming cell response
to SRBC. The suppressive effect of PBB on mito-
gen responsiveness is indicated by a marked effect
(p < 0.01) in the overall dose response trend to all
Environmental Health Perspectives 228Table 1. Body and selected organ weights in mice exposed to PBB.0
PBB
dosage, Body weight, Spleen weight, Spleen/body Thymus weight, Thymus/body
mg/kg g g weight x 103 g weight x 103
0 24.37 ± 2.54b 0.104 ± 0.019 4.3 ± 0.7 0.041 ± 0.009 1.7 ± 0.5
0.03 25.97 ± 1.46 0.101 ± 0.006 3.9 ± 0.2 0.040 ± 0.003 1.6 ± 0.1
0.3 27.60 ± 3.11 0.096 ± 0.008 3.5 ± 0.2c 0.047 ± 0.003 1.7 ± 0.3
3.0 25.33 ± 2.99 0.100 ± 0.013 4.0 ± 0.5 0.045 ± 0.003 1.8 ± 0.1
30.0 24.27 ± 0.80 0.079 ± 0.014d 3.3 ± 0.6d 0.036 ± 0.010 1.5 ± 0.4
a At least three animals were observed in each dosage group.
b The results are recorded as the mean ± S. D.
cp <0.05.
dp < 0.10.
Table 2. Body and selected organ weights in rats exposed to PBB.a
PBB
dosage, Body weight, Spleen weight, Spleen/body Thymus weight, Thymus/body
mglkg g g weight x 103 g weight x 103
0 309.45 ± 18.87b 0.670 ± 0.039 2.2 ± 0.06 0.270 ± 0.021 0.9 ± 0.02
0.03 319.77 ± 21.54 0.663 ± 0.051 2.1 ± 0.03c 0.305 ± 0.016d 1.0 ± 0.08d
0.3 299.17 ± 8.00 0.633 ± 0.045 2.1 ± 0.12 0.264 ± 0.028 0.9 ± 0.12
3.0 315.07 ± 3.32 0.636 ± 0.034 2.0 ± 0.11c 0.242 ± 0.013c 0.8 ± 0.03d
30.0 243.17 ± 6.70d 0.527 ± 0.013d 2.2 ± 0.02 0.159 ± 0.008d 0.7 ± 0.02d
a At least three animals were observed in each dosage group.
b The results are recorded as the mean ± S. D.
cp <0.1.
dp < 0.05.
three mitogens tested (Fig. IA-C). The suppressed
mitogenic reactivity was most clearly demonstra-
table in the 3.0 and 30.0 mg/kg dosage groups with
the T-cell mitogens (PHA and Con A) and in the
30.0 mg/kg group with the B-cell mitogen (LPS); all
mean values at these dosage groups being statis-
tically significant (p < 0.10 orp < 0.01). Enumera-
tion of IgM antibody plaque-forming cells to SRBC
did not reveal any statistically significant differ-
ences between control and treated animals (Fig.
1D). However, the PFC response to SRBC in the
30.0 mg/kg dosage group with a geometric mean of
429 PFC/106 splenic lymphocytes was 27% lower
than in controls with 584 PFC.
In Figure 2 the reactivity of splenic lymphocytes
from PBB exposed rats to the mitogens PHA, Con
A and PWM as well as the antibody response to
SRBC is summarized. PWM rather than E. coli LPS
was employed to evaluate B-cell reactivity due to the
poor stimulation ofnormal splenic lymphocytes from
Fisher rats to E. coli LPS (unpublished observa-
tions). A suppressive effect due to PBB was indi-
cated by the overall dose response trend following
mitogenic stimulation with the T-cell mitogens PHA
(p <0.01) and Con A (p <0.1) (Fig. 2A,B). Marked
depression of mitogenic stimulation, however, oc-
curred only in the 3.0 and 30.0 mg/kg groups with
PHA (p < 0.05) and in the 30.0 mg/kg group with
Con A (p < 0.05). A dose-response trend was not
found with PWM, a polyclonal T- and B-cell ac-
tivator (Fig. 2C). The SRBC antibody titers were
similar in treated and control rats (Fig. 2D).
SerumIgGl, IgG2, IgM, andIgAconcentrations in
PBB treated and control mice are depicted in Table
3. A decrease in serum levels ofall three classes and
subclasses tested occurred at the 30.0 mg/kg dosage
group. However, only the decreases in serum IgM
and IgG2 were statistically significant. Statistically
significant differences in serum immunoglobulin
concentrations in mice exposed to 0.03, 0.3, or 3.0
mg/kg concentrations of PBB were not found.
Discussion
In studies where toxicosis was induced by feeding
PBB a variety ofnonspecific clinical signs as well as
specific repeatable pathologic tissue changes have
been observed. The nonspecific clinical signs such as
anorexia, dehydration, diarrhea, and excessive lac-
rimation and salivation have been reported among
accidentally contaminated farm animals in Michigan
but notincontrolled studies (2, 9). However, specific
gross pathological changes including subcutaneous
edema, atrophy of the thymus and fetal death with
concommitant necrosis ofcotyledons as well as his-
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FIGURE 1. Effect ofPBB exposure in mice on the responsiveness
of splenic lymphocytes to mitogen stimulation and SRBC
splenic plaque forming cells: (.) individual values; (*) mean
value of the dosage group. The response of splenic lympho-
cytes toPHA (A)and Con A (B) were suppressed atthe 3.0and
30.0 mg/kg levels. The response to LPS (C) was suppressed at
the30.0mg/kglevel.
tological changes particularly in the kidneys, gall
bladder, and eyelids have been present in animals
initially contaminated with PBB (10). Based on the
present studies immune function, particularly cell
mediated immunity, also appears to be effected.
Mice exposed to PBB at 3.0 and 30 mg/kg levels
and rats exposed to 30 mg/kg levels had impaired
cell-mediated immune functions as evidenced by re-
duced mitogenic stimulation by the polyclonal T-cell
activators PHA and Con A. In addition, there was a
reduction oflymphoid organ weights at the 30 mg/kg
level in both mice and particularly in rats. That im-
munosuppression may be a more subtle effect ofex-
posure to PBB than either relative organ weights or
microscopic examination is suggested by thefactthat
mice at the 3.0 mg/kg level were immunosuppressed
while organ weights and histology were normal. In
this respect, mice exposed to levels ofTCDD, a po-
tent immunosuppressive environmental chemical,
that do not produce thymic atrophy were found to
have increased susceptibility to infection with Sal-
monella bern, an infection which is dependent upon
cell-mediated immunity (11).
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FIGURE2. EffectofPBB exposure inratsontheresponsiveness of
splenic lymphocytes to mitogen stimulation and antibody tit-
ers to SRBC: (.) individual values; (*) mean value of the
dosage group. The response of splenic lymphocytes to PHA
(A) was suppressed atthe 3.0and 30.0 mg/kglevels andtoCon
A (B) at the 30 mg/kg level. Significant differences were not
observed in the response to PWM (C) on SRBC immunization
(D)betweencontrolandexposedanimals.
Although PBB appears to primarily effect cell-
mediated (T-cell) immunity, humoral immune func-
tions were also depressed in mice at the 30 mg/kg
dose level. This was evidenced by statistically
significant decreases in the in vitro mitogenic re-
sponse to the polyclonal B-cell activator LPS, and
serum IgG and IgM levels as well as slight reductions
in relative spleen weights and the primary antibody
response to SRBC. Reduction of relative spleen
weights were also noted in rats at the 3.0 mg/kg level
but functional humoral immune tests including anti-
body synthesis and in vitro mitogenic response to
PWM did not indicate that immunosuppression had
occurred. It is quite conceivable, however, that if
more sensitive functional immune tests were avail-
able, suppression of humoral immunity would have
been observed in rats. This reduction of humoral
immune responsiveness appears analogous to earlier
studies in guinea pigs fed hexabromobiphenyl (Fire-
Master BP-6) for 45 days (12). In these studies a
slightly reduced primary antibody response (50%)
occurred in the 10 ppm group and significant reduc-
tion occurred at the 50 ppm group in animals im-
Environmental Health Perspectives 230Table 3. Serum immunoglobulin concentrations in normal and PBB-treated mice.
Dosage, Number
mg/kg tested IgGI, mg-%a IgG2, mg-%a IgM, mg_%a IgA, mg-%a
0 7 71 22 283 + 19 26.5 ± 2 17.8 ± 5
0.03 4 120 11 297 ± 20 26.9 ± 2 18.2 ± 6
0.3 4 36 10 254 ± 0 26.8 ± 1 15.3 ± 3
3.0 4 77 19 266 ± 7 23.5 ± 2 13.5 ± 3
30.0 4 40 8 216 + 4b 17.4 ± Ic 9.4 ± 5
a Geometric means ± S. E.
bp < 0.10.
Cp <0.01.
munized against tetanus toxoid. The secondary (IgG)
antibody response was significantly depressed in
both groups.
Limited studies on the immunosuppressive effect
induced by PCB suggests that PBB-induced im-
munosuppression is similar to that found with PCB.
Feeding 50 ppm of Clophen A60 or Aroclor 1260,
commercial PCB preparations, for 6 or 8 weeks in
guinea pigs caused thymic atrophy and significantly
reduced the antibody response to tetanus toxoid and
the delayed hypersensitivity response to tuberculin
(12, 13). However, part of the immunosuppressive
effects caused byfeeding PCB may have been due to
the presence of chlorinated dibenzofurans as toxic
impurities in commercial PCB preparations. In this
respect, 2,3,7,8-tetrachlorodibenzofuran has recently
been shown to cause severe thymus atrophy in a
number of experimental animals (14).
It was noted that while high levels of PBB were
generally immunosuppressive, lower levels tended to
enhance immune activity. Forexample, in mice PHA
responsiveness was slightly elevated at the 0.03 ppm
level and enhanced responses to Con A occurred at
both the 0.03 and 0.3 ppm dose levels. Similarly, en-
hanced PHA and Con A reactivity of splenic lym-
phocytes occurred in rats at the 0.03 and 0.3 ppm
levels. Increases in absolute and relative thymic
weights immediately following exposure of rats to
0.03 ppm ofPBB lend support to these observations.
In this respect, Bonnyns and Botonsky (15) reported
that treatment of rats with low levels of PCB en-
hances PHA reactivity oflymphocytes. Additionally,
low level exposure to heavy metals such as lead (16),
or cadmium (17) results in enhanced antibody re-
sponse while higher levels exerts an immediate
depressive effect (18, 19).
There is no evidence thatenvironmental chemicals
which induce immunosuppression do so through di-
rectmechanisms. However, there areawide varietyof
physiological and pathological conditions that, if al-
teredbytoxic chemicals, wouldindirectly alterthe im-
mune system. For example, hormones such as adre-
nal glucocorticoids (20) and estrogens (21) have
been reported either to enhance or depress various
cellular and humoral immune functions. In unrelated
studies, feeding mice low levels ofPCB resulted in a
decrease in plasma corticoid levels (22) while higher
doses of PCB increased serum corticoid levels (23).
It is quite conceivable that low levels of PBB de-
press circulating corticosteroid levels resulting in
enhanced immune responsiveness while high levels
increase circulating corticosteroid levels causing an
adverse effect on the immune system. Alternatively,
a-fetoprotein which is synthesized in fetal liver, a
primary target organforPBB (24), maybe induced or
depressed. Recently, a-fetoprotein has beenfound to
possess immunoregulatory capabilities (25). Liver
pathology was noted in mice and rats at the 20 mg/kg
levels (unpublished observations). Finally, it has
been suggested that PBBs cause impairment in ab-
sorption and/or utilization of specific nutrients as
evidenced by pair-feeding studies in Japanese quail
and chickens following ingestion of 500 ppm of
PBB-contaminated feed (26). Depression ofhumoral
responses (27, 28) and depression (28) or enhance-
ment (29) ofcellular immune response have been ob-
served in studies ofexperimental malnutrition. How-
ever, the immune alterations may be related to
changes in serum levels of glucocorticoids as found
in children with protein calorie malnutrition (30) and
in undernourished young rats (31).
In conclusion, the mechanisms responsible for
PBB-induced immunosuppression are uncertain. In
any case, exposure to PBB may be more undesirable
than previously thought, as it may lead to immune
modulation in humans as in rodents. The mech-
anisms of immune modulation by PBB is being
studied.
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